Applications published 22 August 2007

Published: 20-Jul-2008


Medicament and system for the percutaneous administration of medicaments
Meddrop Technology 1819317*

Dried forms of aqueous solubilised bile acid dosage formulations
Yoo, Seo Hong 1819318*

Pharmaceutical compsns of amorphous atorvastatin and process for preparing same
Warner-Lambert 1819319*

Orally dispersible pharmaceutical compsn and process for the preparation thereof
Aziende Chimiche Riunite Angelini Francesco 1819320*

Formulations of substituted benzoxazoles
Wyeth 1819321*

Formulations of substituted benzoxazoles
Wyeth 1819322*

Pharmaceutical compsn containing an anti-nucleating agent
Merck 1819323*

Solid particles from controlled destabilisation of microemulsions
Australian Nuclear Science and Technology Organisation 1819324*

Device for ophthalmic drug delivery
Alcon 1819325*

Dosage regimen of an S1P receptor agonist
Novartis 1819326*

Inhalation medicament containing an anti-cholinesterase drug, salmeterol and a steroid selected from the ciclesonide or mometasone furoate group
Boehringer Ingelheim International 1819327*

Adjunctive therapy for depression
SK Corp 1819328*

Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
Schering 1819329*

5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the KV family
Devgen 1819330*

Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof
Novartis 1819331*

Pyrrolopyridine-2-carboxylic acid amides
Prosidion 1819332*

Method of treating HIV infection through co-administration of tipranavir and GW873140
Boehringer Ingelheim International 1819333*

Methods of treating erythropoietin-resistance
Shiva Biomedical 1819334*

Method for treating HIV infection through co-administration of tipranavir and SCH-417690
Boehringer Ingelheim International 1819335*

Dose forms comprising VX-950 and their dosage regimen
Vertex Pharmaceuticals 1819336*

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake or norepinephrine, dopamine and serotonin
AMR Technology 1819337*

Tubulin binding anticancer agents and prodrugs thereof
Threshold Pharmaceuticals 1819338*

A combination of N-(3-metoxy-5-methylpyrazin-2-yl)-2-(4-1",3,4-oxadiazol-2-yluphenyl)pyridine-3-sulphonamide and an anti-mitotic agent for the treatment of cancer
AstraZeneca 1819339*

Methods and compsns for the treatment of pulmonary hypertension of the newborn
Biomarin Pharmaceutical 1819340*

IL-12 modulatory compounds
Synta Pharmaceuticals 1819341*

Quinoline tachykinin receptor antagonists
Merck 1819342*

A method of administering anti-angiogenic agents and a method of treating disease using same
EntreMed 1819343*

Separation of fulvestrant isomers
Sicor 1819344*

Use of lipid conjugates in the treatment of disease
Yissum Research Development Company of the Hebrew University of Jerusalem 1819345*

Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases
Centocor; Johnson & Johnson Research 1819346*

Treating acute excerbations of asthma using a ketolide
Aventis Pharmaceuticals 1819347*

Method of treating HIV infection through co-administration of tipranavir and GW695634
Boehringer Ingelheim International 1819348*

Enhancing treatment of HIF-1 mediated disorders with adenosine A3 receptor agonists
King Pharmaceuticals Research and Development 1819349*

Pharmaceutical formulations cytidine analogues and derivatives
SuperGen 1819350*

Poncirus trifoliata extract for preventing and treating ischaemic heart diseases and pharmaceutical compsn and health food containing the same
Purimed 1819351*

Pharmaceutical compsns from carapa guianensis
Fiocruz, Fundacaeo, Oswaldo, Cruz 1819352*

Compsn for proteosome inhibition
Proteolix 1819353*

Methods and compsns for treating diabetes
BioStratum 1819354*

Methods of using chimeric coiled-coil membrane
Genexel-Sein 1819355*

Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof
Biopharmacopae Design International 1819356*

Vaccines for the rapid response to pandemic avian influenza
University of Pittsburgh of the Commonwealth System of Higher Education 1819357*

Antibodies against vascular endothelial growth factor receptor-1
ImClone Systems 1819358*

Anti-integrin immunoconjugates, methods and uses
Centocor 1819359*

Method of treating microorganisms in the oral cavity via photodynamic therapy employing a non-coherent light source
Kennedy, John 1819360*

Pharmaceutical compsns
Novartis 1819361*

Topical nepafenac formulations
Alcon 1819362*

Method for the production of albumen conjugates with non-steroidal antirheumatic drugs (NSAR)
Albupharm Heidelberg 1819363*

Immunomodulatory compsns, combinations and methods
3M Innovative Properties 1819364*

Compsns and methods for inducing an immune response in a mammal and methods of avoiding an immune response agents such as short interfering RNAs
Alnylam Pharmaceuticals; Hartmann, Gunther; Hornung, Veit; Endres, Stefan 1819365*

A staining compsn for staining an ophthalmic membrane
Kyushu University 1819366*

Use of endothelin ETB receptor agonists and ETA receptor antagonists in tumour imaging
The Board of Trustees of the University of Illinois 1819367*

Sulphonamide compounds as cysteine protease inhibitors
Bayer Schering Pharma 1819667*

Novel 2-cyano-3-(halo)alkoxy-benzenesulphonamide compounds for combating animal pests
BASF 1819668*

Novel inhibitors of histone deacetylase for the treatment of disease
Kalypsys 1819669*

12-aryl prostaglandin analogues
Allergan 1819670*

HCV inhibitors with carbazole structures
SmithKline Beecham 1819671*

Indole-2-carboxylic acid amides
Prosidion 1819672*

Indole derivatives for use as PPAR active compounds
Plexxikon 1819673*

Fused aminopiperidines as depeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
Merck 1819674*

5-amino-4-hydroxy-2-isopropyl-7-y4-methoxy-3-(3-methoxypropoxy)benzyl-8-methylnonanamides
Speedel Experimenta 1819675*

5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
Merck 1819676*

8-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
Merck 1819677*

Rylene tetracarboxylic acid diimides substituted by cyclic amino groups
BASF 1819678*

2-alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compsns containing them and use thereof
Aventis Pharma 1819679*

Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compsns containing them and use thereof
Aventis Pharma 1819680*

7-(2H-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidaemia
Warner-Lambert 1819681*

Potassium salt of an HIV integrase inhibitor
Merck; Istituto di Richerche di Biologia Molecolare P Angeletti; Merck Sharp & Dohme 1819683*

Substituted piperazines as CB1 antagonists
Schering 1819684*

5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
Novartis 1819686*

Cytotoxic agents comprising new C02 modified taxanes
Aventis Pharma 1819687*

Crystalline forms of docetaxel and processes for their preparation
Sicor 1819688*

1-alkynyl-2-aryloxyalkylamides and their use as fungicides
Syngenta Participations; Syngenta Ltd 1819689*

Chroman compounds
Pfizer 1819690*

Bioarloxymethylarene carboxylic acids
F Hoffmann-Roche 1819691*

3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
Nissan Chemical 1819692*

Antithrombitic diamides
Eli Lilly 1819693*

You may also like